KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Inventory: 2014-2025

Historic Inventory for Travere Therapeutics (TVTX) over the last 11 years, with Sep 2025 value amounting to $5.5 million.

  • Travere Therapeutics' Inventory fell 12.71% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year decrease of 12.71%. This contributed to the annual value of $6.2 million for FY2024, which is 34.11% down from last year.
  • Per Travere Therapeutics' latest filing, its Inventory stood at $5.5 million for Q3 2025, which was up 35.65% from $4.1 million recorded in Q2 2025.
  • In the past 5 years, Travere Therapeutics' Inventory ranged from a high of $20.8 million in Q3 2023 and a low of $3.9 million during Q1 2025.
  • Over the past 3 years, Travere Therapeutics' median Inventory value was $6.2 million (recorded in 2024), while the average stood at $8.4 million.
  • Its Inventory has fluctuated over the past 5 years, first soared by 184.68% in 2023, then crashed by 69.40% in 2024.
  • Quarterly analysis of 5 years shows Travere Therapeutics' Inventory stood at $7.3 million in 2021, then slumped by 38.15% to $4.5 million in 2022, then surged by 108.05% to $9.4 million in 2023, then plummeted by 34.11% to $6.2 million in 2024, then fell by 12.71% to $5.5 million in 2025.
  • Its Inventory was $5.5 million in Q3 2025, compared to $4.1 million in Q2 2025 and $3.9 million in Q1 2025.